Ring chromosome 13 syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:96176Q93.2
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Ring chromosome 13 syndrome (also known as r(13) syndrome) is a rare chromosomal disorder in which both ends of chromosome 13 are deleted and the remaining chromosome forms a ring structure. The clinical presentation is highly variable and depends on the amount of genetic material lost during ring formation. The condition affects multiple body systems, most notably the nervous system, musculoskeletal system, and craniofacial structures. Common features include intellectual disability of variable severity, microcephaly, facial dysmorphism (including a prominent nasal bridge, thin upper lip, and large or low-set ears), short stature, and genital anomalies in males (such as hypospadias or ambiguous genitalia). Retinoblastoma may occur in cases where the RB1 gene on chromosome 13q14 is deleted as part of the ring formation. Additional clinical features can include limb anomalies such as thumb hypoplasia or aplasia, foot abnormalities, and overlapping toes. Some patients may present with congenital heart defects, anal atresia, or eye abnormalities. Growth retardation is frequently observed both prenatally and postnatally. The degree of intellectual disability ranges from mild to severe and correlates with the extent of chromosomal material lost. Ring chromosome instability during cell division can lead to mosaicism, with some cells losing the ring chromosome entirely (monosomy 13) or duplicating it, which further contributes to phenotypic variability. There is no cure for ring chromosome 13 syndrome, and management is supportive and symptom-based. Treatment may include early intervention programs, speech and occupational therapy, surgical correction of congenital anomalies (such as cardiac defects or anal atresia), and regular ophthalmologic screening for retinoblastoma when the RB1 locus is deleted. Genetic counseling is recommended for affected families. Long-term follow-up with a multidisciplinary team including geneticists, neurologists, cardiologists, and developmental specialists is essential for optimizing outcomes.

Also known as:

Clinical phenotype terms— hover any for plain English:

Primary hypothyroidismHP:0000832Aplasia/hypoplasia involving bones of the handHP:0005927
Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Ring chromosome 13 syndrome.

View clinical trials →

No actively recruiting trials found for Ring chromosome 13 syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Ring chromosome 13 syndrome community →

No specialists are currently listed for Ring chromosome 13 syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Ring chromosome 13 syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Ring chromosome 13 syndromeForum →

No community posts yet. Be the first to share your experience with Ring chromosome 13 syndrome.

Start the conversation →

Latest news about Ring chromosome 13 syndrome

No recent news articles for Ring chromosome 13 syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Ring chromosome 13 syndrome

What is Ring chromosome 13 syndrome?

Ring chromosome 13 syndrome (also known as r(13) syndrome) is a rare chromosomal disorder in which both ends of chromosome 13 are deleted and the remaining chromosome forms a ring structure. The clinical presentation is highly variable and depends on the amount of genetic material lost during ring formation. The condition affects multiple body systems, most notably the nervous system, musculoskeletal system, and craniofacial structures. Common features include intellectual disability of variable severity, microcephaly, facial dysmorphism (including a prominent nasal bridge, thin upper lip, and

How is Ring chromosome 13 syndrome inherited?

Ring chromosome 13 syndrome follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Ring chromosome 13 syndrome typically begin?

Typical onset of Ring chromosome 13 syndrome is neonatal. Age of onset can vary across affected individuals.